EXTENDING PEGINTERFERON ALFA-2A THERAPY IN PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B WHO DID NOT ACHIEVE A RESPONSE AT WEEK 48 CAN LEAD TO HBEAG SEROCONVERSION AND HBSAG CLEARANCE
HEPATOLOGY（2009）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined